Tissue-specific role of Nrf2 in the treatment of diabetic foot ulcers during hyperbaric oxygen therapy. [electronic resource]
Producer: 20200615Description: 53-62 p. digitalISSN:- 1873-4596
- Aged
- Biomarkers -- metabolism
- Chemokine CCL2 -- genetics
- Chemokine CXCL10 -- genetics
- Diabetic Foot -- genetics
- Epidermal Growth Factor -- genetics
- Female
- Fibroblast Growth Factor 2 -- genetics
- Gene Expression Regulation
- Humans
- Hyperbaric Oxygenation -- methods
- Interleukin-8 -- genetics
- Macrophages -- cytology
- Male
- Middle Aged
- NF-E2-Related Factor 2 -- agonists
- Neovascularization, Physiologic -- drug effects
- Nitric Oxide Synthase Type III -- genetics
- Nitrites -- agonists
- Organ Specificity
- Oxygen -- therapeutic use
- Platelet-Derived Growth Factor -- genetics
- Vascular Endothelial Growth Factor A -- genetics
- Wound Healing -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.